BridgeBio Oncology Therapeutics, Inc. · NASDAQ:BBOT

BridgeBio Oncology Therapeutics, Inc. shareholders

As of Sep 30, 2026, 87 institutions reported holding BridgeBio Oncology Therapeutics, Inc., 75.1% of its shares. Largest: Cormorant Asset Management, LP, BlackRock and Omega Fund Management, LLC. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of BridgeBio Oncology Therapeutics, Inc.ChangeFiled
Cormorant Asset Management, LP17.9M22.3%no changeNov 16, 2026
BlackRock4.01M5.0%+1.86MNov 13, 2026
Omega Fund Management, LLC3.29M4.1%no changeNov 16, 2026
Deerfield Management Company, L.P.3.14M3.9%−1.75MNov 16, 2026
Alphabet Inc.2.82M3.5%no changeNov 5, 2026
Citadel2.7M3.4%+79,250Nov 16, 2026
Enavate Sciences Gp, LLC2.63M3.3%no changeNov 16, 2026
Regents Of The University Of California2.51M3.1%newOct 26, 2026
Vanguard2.27M2.8%−41,728Nov 13, 2026
Armistice Capital, LLC2.26M2.8%+500KNov 16, 2026

BridgeBio Oncology Therapeutics, Inc. insider trades